This compound is a fluorinated nucleoside analog intermediate. It features a modified tetrahydrofuran core with multiple benzoyl ester protecting groups and a benzamido-substituted pyrimidine base.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
2-Deoxy-2-fluoro-1,3,5-tri-O-benzoyl-D-ribofuranose
pharmaceutical intermediate
2-(Hydroxymethyl)-6-imino-7-methyl-2,3,3a,9a-tetrahydro-6H-furo[2',3':4,5][1,3]oxazolo[3,2-a]pyrimidin-3-ol--hydrogen chloride (1/1)
pharmaceutical intermediate
4,6-Dichloro-1-(2,3,5-tri-O-acetyl-beta-L-ribofuranosyl)-1H-imidazo[4,5-c]pyridine
pharmaceutical intermediate
2'-Fluoro-2'-deoxyadenosine
pharmaceutical intermediate
9-((2-Acetoxyethoxy)methyl)-2-amino-6-chloropurine
pharmaceutical intermediate
Pyronaridine Impurity 16
pharmaceutical intermediate
2-Fluoro-5-nitrophenylboronic acid
pharmaceutical intermediate
N²,N⁶-Bis(tert-butoxycarbonyl)-N-[(2S)-1-phenylpropan-2-yl]-L-lysinamide
pharmaceutical intermediate
The international HS code for Cytidine, N-benzoyl-2'-deoxy-2'-fluoro-2'-methyl-, 3',5'-dibenzoate, (2'R)- (CAS 817204-32-3) is 2934.99.
2934.99
2934 99 90
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
[(2R,3R,4R,5R)-5-(4-benzamido-2-oxopyrimidin-1-yl)-3-benzoyloxy-4-fluoro-4-methyloxolan-2-yl]methyl benzoate
MXEQSUUFNWPUJH-RDWHIKKYSA-N
C[C@]1([C@@H]([C@H](O[C@H]1N2C=CC(=NC2=O)NC(=O)C3=CC=CC=C3)COC(=O)C4=CC=CC=C4)OC(=O)C5=CC=CC=C5)F
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.